Drug profile · INN
doxorubicin hydrochloride liposome+irinotecan
- Patents linked
- 0
- News articles
- 0
Quick answer
doxorubicin hydrochloride liposome+irinotecan is an FDA-listed pharmaceutical active ingredient.
Key facts
INN doxorubicin hydrochloride liposome+irinotecan
Frequently asked questions
What is doxorubicin hydrochloride liposome+irinotecan?
doxorubicin hydrochloride liposome+irinotecan is an FDA-listed pharmaceutical active ingredient.